Nan Du

Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring <i>c-Kit</i> Mutation or Amplification

Jun Guo, Lu Si, Yan Kong et al. · Journal of Clinical Oncology · 2011 · 680 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Dysbiosis of maternal and neonatal microbiota associated with gestational diabetes mellitus

Jinfeng Wang, Jiayong Zheng, Wenyu Shi et al. · Gut · 2018 · 454 citations · Full text

Life Sciences, Maternal Health, Microbiology +15

Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion

Nan Du, Xiaosong Li, Fang Li et al. · Oncology Reports · 2013 · 88 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma

Wenjing Xiao, Nan Du, Taoyuan Huang et al. · EBioMedicine · 2018 · 84 citations · Full text

Medicine, Molecular Genetics, Oncology +17

FM-ECG: A fine-grained multi-label framework for ECG image classification

Nan Du, Qing Cao, Yu Li et al. · Information Sciences · 2020 · 59 citations

Engineering, Bioengineering, Biomedical Engineering +12